Galectin-3 impairment of MYCN-dependent apoptosis-sensitive phenotype is antagonized by nutlin-3 in neuroblastoma cells.
MYCN amplification occurs in about 20-25% of human neuroblastomas and characterizes the majority of the high-risk cases, which display less than 50% prolonged survival rate despite intense multimodal treatment. Somehow paradoxically, MYCN also sensitizes neuroblastoma cells to apoptosis, understandi...
Saved in:
| Main Authors: | Veronica Veschi, Marialaura Petroni, Beatrice Cardinali, Carlo Dominici, Isabella Screpanti, Luigi Frati, Armando Bartolazzi, Alberto Gulino, Giuseppe Giannini |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0049139&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Olfactory domain family protein 3 promotes the proliferation of MYCN-amplified neuroblastoma cell lines in vitro
by: ZHANG Yao, ZHANG Xuan, JIA Anna, ZHAN Shijia, GUO Jinxin, CHANG Yan, GUO Yongli
Published: (2025-02-01) -
Targeting MYCN upregulates L1CAM tumor antigen in MYCN-dysregulated neuroblastoma to increase CAR T cell efficacy
by: Laura Grunewald, et al.
Published: (2025-02-01) -
Sunitinib suppress neuroblastoma growth through degradation of MYCN and inhibition of angiogenesis.
by: Raul Calero, et al.
Published: (2014-01-01) -
Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy
by: Anders Valind, et al.
Published: (2023-12-01) -
Evaluation of on growth and metabolism of NB-1691, an MYCN-amplified neuroblastoma cell line
by: Kaitlyn E Wong, et al.
Published: (2018-06-01)